Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Caitlin Truesdale

Weekly Roundup – March 24, 2022

View this email in your browser Weekly Roundup – March 24, 2022  Shipman and Goodwin started a podcast! From Lawyer to Employer: A Shipman Podcast brings you the latest...

| By Caitlin Truesdale

Bactana in pet care agreement with ArcaNatura

Bactana has signed a distribution agreement with France-based ArcaNatura SAS to launch Bactana’s first commercial product, Pawsni™ Glucose Control. FPZ-100, Bactana’s patent pending active ingredient...

| By Caitlin Truesdale

BioCT welcomes JLL as a Supporter Sponsor

JLL is a Fortune 500, leading professional services firm that specializes in commercial real estate in the Life Science sector. Whether your organization is mature,...

| By Caitlin Truesdale

Invea Therapeutics announces poster presentations

Invea Therapeutics reports that an abstract entitled, “Using An Artificial Intelligence and Machine Learning Platform to Identify Mast Cell-Focused Therapeutic Targets for Gut-Brain Axis Disorders,” has...

| By Caitlin Truesdale

Sema4 Named to list of innovative companies

Sema4 has been named to Fast Company’s annual list of the World’s Most Innovative Companies for 2022. “It is an honor that Fast Company has named...

| By Caitlin Truesdale

BioCT welcomes new member Deloitte

Life sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions to address today’s challenges. The Deloitte Life Sciences practice understands...

| By Caitlin Truesdale

Weekly Roundup – March 16, 2022

View this email in your browser Weekly Roundup – March 16, 2022  Boehringer Ingelheim is off to a strong start in ’22 with continued positive...

| By Caitlin Truesdale

Trial of BI Jardiance® shows positive efficacy

A trial evaluating the effect of Boehringer-Ingelheim’s Jardiance® (empagliflozin) in adults with chronic kidney disease will stop early following an assessment of positive efficacy. “We are...

| By Caitlin Truesdale

Yale team focuses on blood-brain barrier

The development and maintenance of the blood-brain barrier are dependent on what is called the Wnt signaling pathway, which regulates a number of crucial cellular...

| By Caitlin Truesdale

Career Newsletter – March 15, 2022

View this email in your browser Career News – March 15, 2022  Artizan Biosciences  Neuroscience Associate Full-time, New Haven Cellifinity Bio  Scientist/Senior Scientist: CAR immune...